Holen Sie sich die Stockscreener-App
6.21
0.32%
-0.02
Handel nachbörslich:
6.20
-0.010
-0.16%
Schlusskurs vom Vortag:
$6.23
Offen:
$6.29
24-Stunden-Volumen:
41,179
Relative Volume:
0.25
Marktkapitalisierung:
$45.62M
Einnahmen:
$7.00M
Nettoeinkommen (Verlust:
$-70.79M
KGV:
-0.6409
EPS:
-9.69
Netto-Cashflow:
$-64.34M
1W Leistung:
+0.81%
1M Leistung:
+59.23%
6M Leistung:
+41.78%
1J Leistung:
-16.64%
1-Tages-Spanne:
$6.1006
$6.29
1-Wochen-Bereich:
$6.06
$6.30
52-Wochen-Spanne:
$3.5334
$7.74
Kezar Life Sciences Inc Stock (KZR) Company Profile
Firmenname
Kezar Life Sciences Inc
Sektor
Branche
Telefon
650-822-5600
Adresse
4000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Vergleichen Sie KZR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KZR
Kezar Life Sciences Inc
|
6.21 | 45.62M | 7.00M | -70.79M | -64.34M | -9.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Kezar Life Sciences Inc Stock (KZR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-17 | Herabstufung | Jefferies | Buy → Hold |
| 2025-10-17 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-08-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-16 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2018-07-16 | Eingeleitet | Jefferies | Buy |
| 2018-07-16 | Eingeleitet | Wells Fargo | Outperform |
| 2018-07-16 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Kezar Life Sciences Inc Aktie (KZR) Neueste Nachrichten
What Wall Street predicts for Kezar Life Sciences Inc. stock priceQuarterly Market Review & Risk Managed Investment Strategies - newser.com
Can Kezar Life Sciences Inc. stock maintain growth trajectoryJuly 2025 Analyst Calls & Daily Technical Forecast Reports - newser.com
Kezar Life Sciences Inc. stock prediction for this weekWeekly Trend Recap & AI Powered Trade Plan Recommendations - newser.com
Is Kezar Life Sciences Inc. stock attractive for growth ETFsWeekly Risk Report & Free Risk Controlled Daily Trade Plans - newser.com
Real time pattern detection on Kezar Life Sciences Inc. stock2025 Sector Review & Safe Entry Point Alerts - newser.com
Applying Elliott Wave Theory to Kezar Life Sciences Inc.Quarterly Earnings Report & Consistent Profit Trading Strategies - newser.com
Backtesting results for Kezar Life Sciences Inc. trading strategiesWeekly Profit Report & Daily Volume Surge Trade Alerts - newser.com
Published on: 2025-11-01 12:41:38 - newser.com
Published on: 2025-11-01 12:24:27 - newser.com
Visual trend scoring systems applied to Kezar Life Sciences Inc.2025 Price Action Summary & Reliable Entry Point Trade Alerts - newser.com
Is Kezar Life Sciences Inc. stock a buy on dipsQuarterly Trade Report & Daily Stock Trend Reports - newser.com
Can Kezar Life Sciences Inc. (2KZ0) stock sustain double digit ROEWeekly Profit Report & Verified Entry Point Detection - newser.com
Kezar Life Sciences, Inc.Common Stock (NQ: KZR - FinancialContent
Kezar Life Sciences (KZR) Price Target Decreased by 52.00% to 6.12 - MSN
Can Kezar Life Sciences Inc. stock continue upward trendWeekly Investment Report & Verified Entry Point Signals - newser.com
Why Kezar Life Sciences Inc. (2KZ0) stock attracts wealthy investorsChart Signals & Real-Time Chart Pattern Alerts - newser.com
How Kezar Life Sciences Inc. stock reacts to inflationary pressuresMarket Trend Review & Technical Buy Zone Confirmations - newser.com
Published on: 2025-10-31 03:56:34 - newser.com
Why hedge funds are buying Kezar Life Sciences Inc. stockJuly 2025 Highlights & Technical Entry and Exit Alerts - newser.com
Building trade automation scripts for Kezar Life Sciences Inc.Trade Analysis Summary & Real-Time Market Sentiment Alerts - newser.com
Kezar Life Sciences Faces Existential Crisis After Clinical Trial Setback - AD HOC NEWS
How to interpret RSI for Kezar Life Sciences Inc. stockTrade Performance Summary & Long-Term Capital Growth Strategies - newser.com
Is Kezar Life Sciences Inc. reversing from oversold territoryMarket Movers & Consistent Growth Equity Picks - newser.com
Developing predictive dashboards with Kezar Life Sciences Inc. dataJuly 2025 Spike Watch & Free Reliable Trade Execution Plans - newser.com
Kezar Life Sciences, Inc. (KZR) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Advanced analytics toolkit walkthrough for Kezar Life Sciences Inc.Trade Volume Summary & Stock Market Timing Techniques - newser.com
Finanzdaten der Kezar Life Sciences Inc-Aktie (KZR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):